On September 28 the Stanford Medicine News Center published a look at the nerve cells that can mark schizophrenia. When not firing, nerve cells are “supposed to keep quiet.” When they start, “popping off at random” it can obscure the intended signals. In the most...
Schizophrenia
Category
University of Pennsylvania-Led Research Discovers Second Type of Schizophrenia
A multicenter research led by the University of Pennsylvania reveals that based on an in-depth analysis of over 300 patients, it would appear that there are two distinct neuroanatomical subtypes of schizophrenia. With the results published in the online...
University of Georgia-based Research Uncovering Significant Opportunity to Treat Schizophrenia
Ongoing research by a University of Georgia psychologist reveals that targeting one particular symptom of schizophrenia has a positive effect on other systems, offering significant promise for treating an aspect of schizophrenia that currently has no actual...
MRC London Institute of Medical Sciences with Breakthrough in Understanding Schizophrenia
Researchers from the Medical Research Council (MRC) London Institute of Medical Sciences report that based on a recent study powered by advanced scanning technology, they are able to associate lower levels of a protein in connection with neurons in schizophrenia...
University of Iowa Hospitals and Clinics Study Use of Transcranial Magnetic Stimulation on Brain Disorders such as Autism & Bipolar
The University of Iowa Hospitals and Clinics (UIHC) is now conducting a clinical trial focusing on the brain with the hope that the study could uncover a treatment for certain brain disorders. Called transcranial magnetic stimulation (TMS), the investigational...
Sheba Medical Center Study Confirms Link Between use of Estrogen Patches & Improved Schizophrenia Symptoms
Israeli researchers have confirmed a suspected link between the appliance of estrogen patches and the lessening of symptoms found in women with Schizophrenia. Led by Professor Mark Weiser of Israel’s elite national hospital Sheba Medical Center, Tel HaShomer, the...
Newron Pharma Delays Start of Phase 2/3 Trial of Evenamide for Schizophrenia Citing Safety Concerns
Newron Pharmaceuticals announced the planned Phase II/III clinical trials of evenamide for schizophrenia will be delayed due to safety concerns. The company received communication from the U.S. FDA indicating concern on findings from a recently completed study in...
Researchers Study Drugs to Combat Impairment in Schizophrenia
As reported in EurekAlert! researchers from the UPV/EHU-University of the Basque Country, the University of La Rioja, the BioCruces Health Research Institute and Cibersam Centre for Biomedical Research into Mental Health studied nine clinical trials from across the...
UCLA Researchers Study Genetic Origins of Schizophrenia
UCLA researchers have established a new analytics approach for researching the genetic origins of mental illness using brain cells grown in a dish from human embryonic stem cells. To read more about this study, refer to the article in ScienceDirect. Lead...
Neuroscience Research Australia Schizophrenia Research Breakthrough
Read Nick Lavars’ article in New Atlas reporting that for so long schizophrenia was seen as a disorder exclusively of the mind, but new lines of research are uncovering evidence that its machinations may venture well beyond the brain. In what is being labeled one of...
Simple Algorithm May Improve Schizophrenia Symptoms Sooner
MDLinx writer Marilynn Larkin reports that most patients in the early stages of schizophrenia can achieve symptom remission with sequential administration of amisulpride and clozapine, and the latter should be given after patients fail a single antipsychotic trial,...